Global Glutamate Receptor Ionotropic NMDA 2B Market Growth 2023-2029

Global Glutamate Receptor Ionotropic NMDA 2B Market Growth 2023-2029

LPI (LP Information)' newest research report, the “Glutamate Receptor Ionotropic NMDA 2B Industry Forecast” looks at past sales and reviews total world Glutamate Receptor Ionotropic NMDA 2B sales in 2022, providing a comprehensive analysis by region and market sector of projected Glutamate Receptor Ionotropic NMDA 2B sales for 2023 through 2029. With Glutamate Receptor Ionotropic NMDA 2B sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Glutamate Receptor Ionotropic NMDA 2B industry.

This Insight Report provides a comprehensive analysis of the global Glutamate Receptor Ionotropic NMDA 2B landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Glutamate Receptor Ionotropic NMDA 2B portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Glutamate Receptor Ionotropic NMDA 2B market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Glutamate Receptor Ionotropic NMDA 2B and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Glutamate Receptor Ionotropic NMDA 2B.

The global Glutamate Receptor Ionotropic NMDA 2B market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Glutamate Receptor Ionotropic NMDA 2B is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Glutamate Receptor Ionotropic NMDA 2B is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Glutamate Receptor Ionotropic NMDA 2B is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Glutamate Receptor Ionotropic NMDA 2B players cover BioCrea GmbH, Bristol-Myers Squibb Company, Cerecor Inc., Johnson & Johnson, Luc Therapeutics, Inc., NeurOp, Inc, Novartis AG and UCB S.A., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Glutamate Receptor Ionotropic NMDA 2B market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
JNJ-0808
Neu-2000
NP-10679
NP-11948
Radiprodil
Others

Segmentation by application
Acute Ischemic Stroke
Autism
Brain Ischemia
Burns
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
BioCrea GmbH
Bristol-Myers Squibb Company
Cerecor Inc.
Johnson & Johnson
Luc Therapeutics, Inc.
NeurOp, Inc
Novartis AG
UCB S.A.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Glutamate Receptor Ionotropic NMDA 2B market?

What factors are driving Glutamate Receptor Ionotropic NMDA 2B market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Glutamate Receptor Ionotropic NMDA 2B market opportunities vary by end market size?

How does Glutamate Receptor Ionotropic NMDA 2B break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.